IERARDI, ENZO GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 4.671
EU - Europa 3.790
AS - Asia 1.585
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
AF - Africa 5
SA - Sud America 1
Totale 10.073
Nazione #
US - Stati Uniti d'America 4.664
IE - Irlanda 1.298
CN - Cina 1.162
UA - Ucraina 1.033
SE - Svezia 723
IT - Italia 225
TR - Turchia 212
FI - Finlandia 168
IN - India 156
FR - Francia 137
GB - Regno Unito 120
DE - Germania 52
SG - Singapore 39
RU - Federazione Russa 15
EU - Europa 13
VN - Vietnam 13
CA - Canada 7
BE - Belgio 5
CZ - Repubblica Ceca 5
AU - Australia 4
EG - Egitto 4
NL - Olanda 4
NZ - Nuova Zelanda 4
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
GE - Georgia 1
HK - Hong Kong 1
ID - Indonesia 1
KE - Kenya 1
PL - Polonia 1
SM - San Marino 1
Totale 10.073
Città #
Dublin 1.297
Chandler 917
Jacksonville 732
Dearborn 580
Nyköping 374
Nanjing 373
Wilmington 218
Princeton 146
Ashburn 144
San Mateo 144
Beijing 139
Nanchang 115
Boardman 114
Woodbridge 85
Kunming 73
Hebei 69
Shenyang 69
Ann Arbor 63
Tianjin 59
Des Moines 58
Changsha 50
Jiaxing 43
Hilden 34
Hangzhou 30
Jinan 30
Stevenage 28
Seattle 27
Singapore 26
New York 23
Helsinki 22
Pune 18
Changchun 17
Ningbo 15
Dong Ket 12
Norwalk 12
Taizhou 12
Auburn Hills 11
Philadelphia 11
Zhengzhou 11
Lanzhou 10
Rome 10
Guangzhou 8
Hefei 7
Shanghai 7
Brussels 5
Florence 5
Fuzhou 5
Hanover 5
Los Angeles 5
Napoli 5
Saint Petersburg 5
Borås 4
Fairfield 4
Orange 4
Washington 4
Asti 3
Auckland 3
Bologna 3
Casoria 3
Cedar Knolls 3
Irvine 3
Messina 3
Milan 3
Mountain View 3
Phoenix 3
Sydney 3
Varedo 3
Amsterdam 2
Avigliano 2
Bari 2
Brno 2
Busto Arsizio 2
Foggia 2
Greenwich 2
Haikou 2
Houston 2
Jinhua 2
Kansas City 2
Las Vegas 2
Marta 2
Matelica 2
Modena 2
Monreale 2
Montreal 2
Mumbai 2
Olomouc 2
Opera 2
Pescantina 2
Rockville 2
San Donà Di Piave 2
Toronto 2
Afragola 1
Albano Laziale 1
Andover 1
Arezzo 1
Arluno 1
Bagheria 1
Binh Duong 1
Brasília 1
Cairo 1
Totale 6.387
Nome #
LA COLITE SEGMENTARIA ASSOCIATA AI DIVERTICOLI: USO DEL DEL bECLOMETASONE dipropionatoNELLE FORME EMORRAGICHE 285
Helicobacter Heilmannii: un nuovo batterio dello stomaco. Come si ricerca e suo ruolo nella pratica clinica 128
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. 104
"Clarithromycin-resistant genotypes and eradication of Helicobacter pylori." 100
Argon plasma coagulation in the treatment of haemorragic solitary ulcer syndrome. 98
57. M Barone, E Maiorano, R Ladisa, A Pece, P Berloco, M Strazzabosco, ML Caruso, AM Valentini, E Ierardi, A Di Leo, A Francavilla. Ursodeoxycholate further increases bile duct cell proliferative response induced by partial bile duct ligation in rats. 93
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. 93
Pseudotumoural lesion of the abdominal wall due to a fishbone migration 91
Helicobacter pylori and chronic antral erosions: our experience. 90
The augmenter of liver regeneration induces mithochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mithochondria. 89
Liver damage onset after a single infliximab administration in a patient with refractory ulcerative colitis 86
A case of adverse reaction potentially related to a microbubble contrast agent for ultrasonography. 86
Binding of Campylobacter pylori to human peripheral blood lymphocytes 85
Peritoneo-venous shunting for ascites: a five year experience with LeVeen and Denver shunts. 85
Circadian rhythm of hepatic estrogen receptors 85
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV seronegative pregnant women: a 24 month prospective study. 84
H. pylori antibiotic resistance and 13C urea breath test values. J Med Microbiol. 2010 Jan 21. 84
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost-effectiveness 84
Argon plasma coagulation of haemorragic solitary rectal ulcer syndrome. 84
I breath tests nell’ insufficienza panctreatica, nelle malattie epatiche e nell’ alitosi. 83
Circadian rhythm of hepatic estrogen receptors. 82
Malnutrizione in Gastroenterologia. 82
Modulation of rat Hepatocyte proliferation by bile salts: in vitro and in vivo studies 82
H. pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years 81
An inter and intra-laboratory comparison of breath 13CO2 . 81
"Nutrizione in Gastroenterologia" 81
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. 81
Endoscopic ultrasound localization of a solitary insulinoma of pancreatic tail misdiagnosed as epilepsy: case report 80
Epidemiology of gastroesophageal reflux 80
A life threatning event following the injection of a microbubble contrast agent for ultrasonography. 79
Incidence and risk factors of duodenal ulcer 78
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits 78
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicenter study. 77
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses. 76
Immunohistostaining of hepatitis C virus (HCV) non-structural protein 4 (NS 4) in ependymocytes of uninfected mice: an antigenic mimicry? 75
"Alterazioni dello stato nutrizionale" 75
Autoantibodies reacting with gastric antigens in Helicobacter pylori gastritis of dyspeptic children 74
Gastrospirillum hominis and human chronic gastritis 73
Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. 73
Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study. 73
Immunohistochemical detection of Helicobacter Pylori vacuolating cytoxin in the hepatocytes of patients with isolated hypertransaminasemia 73
I nucleotidi ciclici (cAMP e cGMP) nell' ascite come markers di recidiva da carcinoma ovarico. 73
Cyclic nucleotides in ascites from ovarian carcinoma 73
Pattern of apoptosis in Crohn’ s disease: a singular aspect. 72
A third-line levofoxacin-based rescue therapy for Helicobacter pylori eradication. 72
Update on Helicobacter pylori research. Malignancies. 72
Effect of Lactobacillus reuteri on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy in children: a randomised clinical trial 72
The pattern of mucosal tumor necrosis factor-α expression in segmental colitis associated to diverticula suggests a truly autonomous clinical entity. 72
Helicobacter species in liver and biliary diseases. 71
Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice 71
Symptoms and pathophysiological correlations in patients with constipation and functional dyspepsia. 71
Role of different clarithromycin resistance genotypes on Helicobacter pylori eradication. 71
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. 71
A new semiquantitative method of quantifying Helicobacter pylori antigen in stools 71
Estrogens, androgens and EGF receptor expression in gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine. 70
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori 70
ER-beta expression in large bowel adenomas: Implications in colon carcinogenesis. 70
Malattia da reflusso gastro-esofageo e dispepsia non ulcerosa. 70
Gastro-esophageal reflux disease and lactose malabsorption: casual comorbidity or neglected association? 70
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrintestinal symptoms 69
Endoultrasonographic guided alcohol lavage of a pancreatic fluid collection: a case report 69
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. 69
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 69
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. 69
Two new treatment regimens for Helicobacter pilori eradication: a randomised study 69
Pathways and gene expression profiles in hepatocellular carcinoma 69
Anisakis pegreffi etiological agent of gastric infections in two Italian women. 68
Campylobacter fetus bacteriemia in an immunocompromised patient: a case report and review of literature. 68
TUMOUR NECROSIS FACTOR ALPHA DOWNREGULATION AND BASIC FIBROBLAST GROWTH FACTOR/SYNDECAN 1 LINK: A POSSIBLE MOLECULAR PATHWAY OF MUCOSAL HEALING IN ULCERATIVE COLITIS 68
Claritromycin resistance and Helicobacter pylori genotypes in Italy. 68
Proliferative Activity of Gastric Epithelium in Progressive Stages of Helicobacter pylori Infection. 68
Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation 68
Ruolo attuale e progressi tecnologici dell’ecografia transaddominale nell’ imaging delle vie biliari 68
High eradication rates for Helicobacter pylori with a new sequential treatment. 67
Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. 67
Tumour necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 67
Tumor necrosis factor alpha in ulcerative colitis and diverticular disease associated colitis. 67
Effect of eradicating therapy on cell proliferation in Helicobacter pylori-related lesions 67
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis. 67
Helicobacter Heilmannii gastritis: a histological and immunohistochemical trait 66
Celiac plexus under endoscopy ultrasonographic guidance complication. 66
There is a role for sequential in sequential anti-H. pylori therapy? (Reply of the authors). 66
Reflux symptoms in professional opera choristers. 66
Lupus nephritis improvement after anti-tumour necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn’s disease: a case report. 66
Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? 66
Tumor necrosis factor alpha in segmental colitis associated with diverticula. 65
Worldwide H. pylori antibiotic resistance: a systematic review. 65
Effects of ranitidine: a short-term clinical trial for duodenal ulcer treatment using two different types of oral administration. Serum prolactin stimulation after bolus injection. 64
“Mycophenolate mofetil in the treatment of autoimmune hcv-associated haematological disorders showing steroid resistance or dependence.” J Viral Hepat 64
The prolongation of triple therapy for Helicobacter pylori does not allows reaching therapeutic outcome of sequential scheme: a prospective, randomized study. 64
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. 64
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori: a multicenter study. 63
Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis 63
The Influence of Lactobacillus brevis on Ornithine Decarboxylase Activity and Polyamine Profiles in Helicobacter pylori Infected Gastric Mucosa 63
Segmental colitis associated with diverticula: A rare clinical entity and a new challenge for the gastroenterologist. 63
Small intestinal contrast ultrasonograpy based scoring system: a promising approach for the diagnosis and follow-up of celiac disease. 63
A oral Tacrolimus long-term therapy in parients with Crohn’s disease and steroid resistance 63
Effects of carbonated water on functional dyspepsia and constipation. 62
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. 62
Gastric Mucosa Alterations in First-Degree Relatives of Gastric Cancer Patients 62
Totale 7.640
Categoria #
all - tutte 40.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.342 532 296 57 56 287 327 319 21 188 28 187 44
2020/20211.135 161 1 154 9 152 154 165 10 153 157 5 14
2021/2022729 147 0 1 10 62 30 35 66 94 69 41 174
2022/20233.441 250 125 114 272 279 387 23 240 1.550 22 84 95
2023/2024454 111 26 22 15 57 149 1 28 0 5 0 40
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 10.123